CAPTRUST FINANCIAL ADVISORS - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$4,0000.0%1,5000.0%0.00%
Q1 2022$4,000
-20.0%
1,5000.0%0.00%
Q4 2021$5,000
-54.5%
1,500
-7.1%
0.00%
Q3 2021$11,000
-21.4%
1,614
+7.6%
0.00%
Q2 2021$14,000
-6.7%
1,5000.0%0.00%
Q1 2021$15,000
-70.6%
1,500
+14.9%
0.00%
-100.0%
Q1 2019$51,0001,3060.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 2,400,000$25,032,0001.43%
TANG CAPITAL MANAGEMENT LLC 1,365,376$14,241,0001.38%
Palo Alto Investors LP 1,343,897$14,017,0000.84%
Sofinnova Investments, Inc. 1,197,630$12,491,0000.79%
Gyon Technologies Capital Management, LP 29,745$310,0000.75%
RICE HALL JAMES & ASSOCIATES, LLC 455,567$4,752,0000.20%
GLOBEFLEX CAPITAL L P 63,226$659,0000.17%
PDT Partners, LLC 188,538$1,966,0000.13%
CADENCE CAPITAL MANAGEMENT LLC 71,179$742,0000.11%
FRED ALGER MANAGEMENT, LLC 2,474,029$25,804,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders